ASX - By Stock
|
ATX |
Re:
Ann: Presentation and Webinar
|
|
vrs37
|
7 |
1.8K |
3 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
7
|
1.8K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
230
|
100K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
0 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
230
|
100K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
1 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
230
|
100K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
230
|
100K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
0 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
230
|
100K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
vrs37
|
230 |
100K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
230
|
100K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ASCO Conference Abstract
|
|
vrs37
|
4 |
1.4K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4
|
1.4K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
72 |
23K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
72
|
23K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
72 |
23K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
72
|
23K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
72 |
23K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
72
|
23K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
5 |
1.5K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
1.5K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vrs37
|
72 |
23K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
72
|
23K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
15K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
15K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
15K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
15K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
15K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
15K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
15K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
44
|
12K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
vrs37
|
48 |
15K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
215K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
640
|
215K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
215K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
640
|
215K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
215K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
640
|
215K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
215K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
640
|
215K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
215K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
640
|
215K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.6K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.6K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.6K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.6K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.6K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
53K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
53K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
53K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
53K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
53K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
53K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
53K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
12K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
12K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
12K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
15K |
0 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
58
|
15K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
24K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
24K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
24K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
24K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
24K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
24K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
24K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
24K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
24K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
24K
|
0
|
|